Doctor profile · Federal record
Dr. Billie Casse, D.O.
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Reno, NV
- NPI 1821119140
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 21 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5452 Reno Corporate Dr
Reno, NV 895112250
(775) 245-2426
fax (775) 245-2380
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- May 12, 2022
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Nevada #DO1493 · Michigan #AS-2762032-274
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1821119140. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,991
Distinct HCPCS
10
Medicare allowed
$146,801
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 645 | 108 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 235 | 176 | $90 | |
11102 |
Biopsy of related skin growth, first growth | 193 | 151 | $91 | |
17000 |
Destruction of precancer skin growth, 1 growth | 169 | 142 | $46 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 164 | 134 | $127 | |
11103 |
Biopsy of related skin growth, each additional growth | 155 | 70 | $51 | |
17110 |
Destruction of skin growth, 1-14 growths | 131 | 112 | $114 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 61 | 43 | $303 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 53 | 50 | $56 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 44 | 44 | $112 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 213. This provider delivers 9.3× the peer median.Open Payments
Industry payments received
All-time total
$1,574
Transactions
69
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 17 | $408.40 | |
| Regeneron Healthcare Solutions, Inc. | 8 | $275.86 | |
| UCB, Inc. | 11 | $271.13 | |
| Lilly USA, LLC | 13 | $184.17 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $94.42 | |
| REVANCE THERAPEUTICS, INC. | 2 | $77.35 | |
| Janssen Biotech, Inc. | 3 | $54.46 | |
| Organon Llc | 2 | $39.72 | |
| Novartis Pharmaceuticals Corporation | 2 | $38.71 | |
| PFIZER INC. | 2 | $33.05 | |
| Incyte Corporation | 1 | $29.26 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $28.28 | |
| GENZYME CORPORATION | 1 | $27.70 | |
| Biofrontera Inc. | 1 | $11.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
260
Patients
155
Total drug cost
$5,257
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mupirocin | Generic | 62 | 51 | $534 |
| Triamcinolone Acetonide | Generic | 43 | 31 | $474 |
| Ketoconazole | Generic | 33 | 18 | $786 |
| Clobetasol Propionate | Generic | 24 | 15 | $1,254 |
| Prednisone | Generic | 19 | 0 | $97 |
| Betamethasone Dipropionate | Generic | 18 | 13 | $1,324 |
| Cephalexin | Generic | 17 | 16 | $113 |
| Doxycycline Hyclate | Generic | 17 | 0 | $395 |
| Hydrocortisone | Generic | 16 | 11 | $147 |
| Minocycline Hcl | Generic | 11 | 0 | $134 |
Frequently asked questions
What is Dr. Billie Casse's medical specialty?
Dr. Billie Casse practices Dermatology Physician in Reno, NV.
Where does Dr. Billie Casse practice?
Dr. Billie Casse practices at 5452 Reno Corporate Dr, Reno, NV 895112250. Office phone: 7752452426.
What is Dr. Billie Casse's NPI?
Dr. Billie Casse's National Provider Identifier (NPI) is 1821119140, issued by NPPES.
Does Dr. Billie Casse accept Medicare assignment?
Yes. Dr. Billie Casse accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Billie Casse commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.